Page last updated: 2024-11-05

tributyl citrate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Tributyl Citrate (TBC) is a colorless, odorless liquid that is commonly used as a plasticizer, solvent, and biocompatible compound. It is synthesized by the esterification of citric acid with butanol. TBC is known for its low volatility, high flash point, and good biocompatibility. It has been widely studied for its potential applications in various fields, including pharmaceuticals, cosmetics, and food additives. TBC is often used as a plasticizer in polyvinyl chloride (PVC) to improve its flexibility and durability. It is also used as a solvent in various industrial applications, including paint, inks, and adhesives. In the pharmaceutical industry, TBC is used as a plasticizer in capsules, tablets, and other dosage forms. It is also used as a solvent for drug delivery systems and as a component of topical creams and lotions. In the cosmetic industry, TBC is used as a moisturizer, emollient, and solvent in various skincare products. Its biocompatibility makes it suitable for use in medical devices and implants. However, there are some concerns about the potential toxicity of TBC at high concentrations, and further research is needed to assess its long-term effects on human health. The extensive research on TBC focuses on understanding its chemical properties, biological effects, and potential applications in various fields, aiming to develop safer and more efficient industrial and pharmaceutical products.'

Cross-References

ID SourceID
PubMed CID6507
CHEMBL ID2107619
CHEBI ID176825
SCHEMBL ID24668
MeSH IDM0118881

Synonyms (59)

Synonym
c18h32o7
tributyl 2-hydroxypropane-1,2,3-tricarboxylate
CHEBI:176825
AKOS015839595
nsc-8491
tri-n-butyl citrate
nsc8491
77-94-1
citric acid, tributyl ester
1,3-propanetricarboxylic acid, 2-hydroxy-, tributyl ester
butyl citrate
n-butyl citrate
tributyl citrate
2-hydroxy-1,3-propanetricarboxylic acid, tributyl ester
citroflex 4
1,2,3-propanetricarboxylic acid, 2-hydroxy-, tributyl ester
inchi=1/c18h32o7/c1-4-7-10-23-15(19)13-18(22,17(21)25-12-9-6-3)14-16(20)24-11-8-5-2/h22h,4-14h2,1-3h
butyl citrate (van)
brn 1806072
2-hydroxy-1,2,3-propanetricarboxylic acid, tributyl ester
ai3-00394
einecs 201-071-2
tributyl 2-hydroxy-1,2,3-propanetricarboxylate
nsc 8491
tributyl citrate, >=97.0%
citric acid tributyl ester
C0366
A839297
1,2,3-propanetricarboxylic acid, 2-hydroxy-, 1,2,3-tributyl ester
827d5b1b6s ,
ec 201-071-2
tributyl citrate [nf]
unii-827d5b1b6s
CHEMBL2107619
morflex tbc
citroflex c 4
FT-0631337
tributyl citrate [inci]
tributyl citrate [usp-rs]
butyl citrate [mi]
tributyl acetylcitrate impurity a [ep impurity]
tributyl citrate [ep impurity]
tributyl citrate [mart.]
SCHEMBL24668
DTXSID5051442
W-104292
tributyl 2-hydroxy-1,2,3-propanetricarboxylate #
citric acid tri-n-butyl ester
mfcd00027217
tributyl citrate, united states pharmacopeia (usp) reference standard
tributyl citrate, pharmaceutical secondary standard; certified reference material
tributyl acetylcitrate imp. a (ep); tributyl 2-hydroxypropane-1,2,3-tricarboxylate; tributyl citrate; tributyl acetylcitrate impurity a
DS-4667
tributyl2-hydroxypropane-1,2,3-tricarboxylate
Q1954892
tributyl 2-hydroxypropane-1,2,3-tricarboxylate (tributyl citrate)
?tributyl citrate
HY-W013762
CS-W014478
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
carbonyl compoundAny compound containing the carbonyl group, C=O. The term is commonly used in the restricted sense of aldehydes and ketones, although it actually includes carboxylic acids and derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (15.38)18.7374
1990's1 (7.69)18.2507
2000's3 (23.08)29.6817
2010's6 (46.15)24.3611
2020's1 (7.69)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 60.44

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index60.44 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.96 (4.65)
Search Engine Demand Index94.87 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (60.44)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (14.29%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]